Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol-Myers Squibb’s KRAS inhibitor Krazati has been approved for a second indication, colorectal cancer (CRC), which could inject some much-needed sales growth into the product. The FDA has given ...

TI has debuted new design resources and power-management chips to help companies meet growing AI computing demands.

Ready to watch NASCAR in 2025 and want NASCAR TV and streaming programming this week? Here is this week’s NASCAR broadcast schedule. All times listed are ET. NASCAR Cup Series: The Xfinity 500 airs on ...